This trial will test a couples-based HIV prevention program to see if it can reduce the risk of HIV transmission for transgender women and their partners.
1 Primary · 0 Secondary · Reporting Duration: Changes in CR-HIV at 12-month follow-up
240 Total Participants · 2 Treatment Groups
Primary Treatment: CHIP · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: